ProMetic BioTherapeutics, Inc. Unveils its New Human Plasma Technology Transfer Center in Maryland, USA

ROCKVILLE, MARYLAND AND MONTREAL, QUEBEC--(Marketwire - Aug. 9, 2007) - ProMetic BioTherapeutics, Inc. (“PBT”), a wholly owned business unit of ProMetic Life Sciences Inc. (TSX:PLI) (“ProMetic”) unveils its new Development and Technology Transfer Center for protein-based therapeutics.

MORE ON THIS TOPIC